Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer

被引:229
作者
Samowitz, Wade S. [1 ]
Albertsen, Hans
Sweeney, Carol
Herrick, Jennifer
Caan, Bette J.
Anderson, Kristin E.
Roger, K. Wolf F.
Slattery, Martha L.
机构
[1] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA
[2] Univ Utah, Hlth Res Ctr, Dept Internal Med, Salt Lake City, UT USA
[3] Kaiser Permanente, Div Res, Oakland, CA USA
[4] Univ Minnesota, Sch Publ Hlth, Dept Epidemiol, Minneapolis, MN USA
关键词
D O I
10.1093/jnci/djj468
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: Cigarette smoking has been associated with microsatellite instability in sporadic colon cancer. Most microsatellite-unstable colon cancers have widespread methylation of CpG islands (i.e., the CpG island methylator phenotype [CIMP]), and many of these tumors harbor the V600E BRAF mutation. We investigated whether the association between smoking and all colon cancers could be explained through induction of CIMP and/or BRAF mutations. Methods: We evaluated 1315 case patients with colon cancer and 2392 control subjects in a population-based study. Demographic information, including smoking history, was obtained in an interview. Microsatellite instability was determined primarily by evaluation of the mononucleotide repeat BAT-26. CIMP was determined by sodium bisulfite modification of DNA followed by methylation-specific polymerase chain reaction amplification of CpG islands in hMLH1, p16, and MINTS1, -2, and -31. Tumors were scored as CIMP high (i.e., >= 2 CpG islands methylated) or CIMP low (i.e., < 2 CpG islands methylated). BRAF V600E mutations were identified by sequencing. Logistic regression was used to quantify relationships among smoking, CIMP, and BRAF. All statistical tests were two-sided. Results: Heavy smoking (i.e., > 20 cigarettes per day), compared with nonsmoking, was associated with an increased risk of CIMP-high colon cancer (odds ratio [OR] = 2.06, 95% confidence interval [CI] 1.43 to 2.97) and also with BRAF V600E mutations (OR 3.16, 95% CI = 1.80 to 5.54). The association between cigarette smoking and the risk of colon cancer was limited to the minority of tumors that were CIMP high and BRAF wild type or CIMP high and BRAF mutated (for heavy smokers, OR = 1.91, 95% CI = 1.23 to 2.97, and OR = 2.85, 95% CI = 1.53 to 5.29, respectively). All relationships above showed a statistically significant relationship to amount smoked (P-trend <.001 for all, except that relationship with tumors that were CIMP high and BRA F wild type, for which P-tend =.008) and were independent of microsatellite instability. Conclusions: Previously identified associations between smoking and colon cancer, whether microsatellite unstable or stable, appear to be explained by the association of smoking with CIMP and BRAF mutations.
引用
收藏
页码:1731 / 1738
页数:8
相关论文
共 39 条
[1]
Belinsky SA, 2002, CANCER RES, V62, P2370
[2]
Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis [J].
Belinsky, SA ;
Nikula, KJ ;
Palmisano, WA ;
Michels, R ;
Saccomanno, G ;
Gabrielson, E ;
Baylin, SB ;
Herman, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11891-11896
[3]
Boland CR, 1998, CANCER RES, V58, P5248
[4]
BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer [J].
Deng, GR ;
Bell, I ;
Crawley, S ;
Gum, J ;
Terdiman, JP ;
Allen, BA ;
Truta, B ;
Sleisenger, MH ;
Kim, YS .
CLINICAL CANCER RESEARCH, 2004, 10 (01) :191-195
[5]
Influence of aromatic hydrocarbon receptor-mediated events on the genotoxicity of cigarette smoke condensate [J].
Dertinger, SD ;
Silverstone, AE ;
Gasiewicz, TA .
CARCINOGENESIS, 1998, 19 (11) :2037-2042
[6]
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing [J].
Domingo, E ;
Laiho, P ;
Ollikainen, M ;
Pinto, M ;
Wang, L ;
French, AJ ;
Westra, J ;
Frebourg, T ;
Espín, E ;
Armengol, M ;
Hamelin, R ;
Yamamoto, H ;
Hofstra, RMW ;
Seruca, R ;
Lindblom, A ;
Peltomäki, P ;
Thibodeau, SN ;
Aaltonen, LA ;
Schwartz, S .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (09) :664-668
[7]
Eguchi K, 1997, CANCER RES, V57, P4913
[8]
Frazier ML, 2003, CANCER RES, V63, P4805
[9]
Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725
[10]
Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands [J].
Herman, JG ;
Graff, JR ;
Myohanen, S ;
Nelkin, BD ;
Baylin, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9821-9826